Microglial Activation and Connectivity in Alzheimer Disease and Aging
暂无分享,去创建一个
Sebastian Schuster | O. Dietrich | M. Ewers | S. Stoecklein | R. Perneczky | O. Pogarell | D. Keeser | P. Bartenstein | A. Rominger | N. Franzmeier | T. Grimmer | M. Brendel | K. Buerger | D. Janowitz | C. Palleis | G. Höglinger | E. Morenas-Rodriguez | A. Finze | F. Eckenweber | G. Biechele | E. Weidinger | B. Rauchmann | C. Kurz | O. Goldhardt | B. Papazov | J. Levin | R. Rupprecht | L. Trappmann | J. Haeckert | M. Tatò | M. Zaganjori | Ersin Ersoezlue | S. Guersel | L. Burow | J. Utecht | P. Bartenstein | Sebastian Schuster | Boris Papazov | S. Stoecklein | Carla Palleis
[1] A. Drzezga,et al. Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases , 2021, Science Translational Medicine.
[2] K. Blennow,et al. Microglial activation and tau propagate jointly across Braak stages , 2021, Nature Medicine.
[3] H. Adelsberger,et al. Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation , 2021, bioRxiv.
[4] A. Danek,et al. Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome , 2021, Frontiers in Aging Neuroscience.
[5] Sebastian Schuster,et al. Impact of TSPO Receptor Polymorphism on [18F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders , 2021, Life.
[6] Yi Wang,et al. Relationship between tau, neuroinflammation and atrophy in Alzheimer's disease: The NIMROD study , 2021, Inf. Fusion.
[7] J. Mulder,et al. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease , 2021, Acta Neuropathologica.
[8] M. Tremblay,et al. Synaptic Loss in Alzheimer's Disease: Mechanistic Insights Provided by Two-Photon in vivo Imaging of Transgenic Mouse Models , 2020, Frontiers in Cellular Neuroscience.
[9] Ukpong B. Eyo,et al. Negative feedback control of neuronal activity by microglia , 2020, Nature.
[10] A. Danek,et al. TSPO PET With 18F-GE-180 to Differentiate Variants of Multiple Sclerosis: Relapsing-Remitting Multiple Sclerosis, Tumefactive Demyelination, and Baló's Concentric Sclerosis. , 2020, Clinical nuclear medicine.
[11] K. Bötzel,et al. In Vivo Assessment of Neuroinflammation in 4‐Repeat Tauopathies , 2020, medRxiv.
[12] Keith A. Johnson,et al. Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease , 2020, Nature Communications.
[13] R. Perneczky,et al. Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid. , 2020, Journal of Alzheimer's disease : JAD.
[14] Rik Ossenkoppele,et al. Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity , 2019, eLife.
[15] T. Hromádka,et al. Intersection of pathological tau and microglia at the synapse , 2019, Acta neuropathologica communications.
[16] Sang Won Seo,et al. Functional connectivity associated with tau levels in ageing, Alzheimer’s, and small vessel disease , 2019, Brain : a journal of neurology.
[17] K. Cosgrove,et al. Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [11C]PBR28 HRRT PET study , 2019, bioRxiv.
[18] P. Expert,et al. Covariance statistics and network analysis of brain PET imaging studies , 2019, Scientific Reports.
[19] Alan C. Evans,et al. Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease , 2019, bioRxiv.
[20] T. Schneider-Axmann,et al. CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum , 2019, Neurobiology of Aging.
[21] L. Tan,et al. Inflammatory markers in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.
[22] J. Trojanowski,et al. Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology , 2019, Molecular Neurodegeneration.
[23] D. Holtzman,et al. Loss of TREM2 function increases amyloid seeding but reduces plaque associated ApoE , 2018, Nature Neuroscience.
[24] N. Albert,et al. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study , 2018, Journal of Neuroinflammation.
[25] Derek H. Oakley,et al. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer’s disease , 2018, Journal of Neuroinflammation.
[26] B. Lamb,et al. Inflammation as a central mechanism in Alzheimer's disease , 2018, Alzheimer's & dementia.
[27] D. Brooks,et al. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer’s disease , 2018, Brain : a journal of neurology.
[28] C. Steinhäuser,et al. Plaque‐dependent morphological and electrophysiological heterogeneity of microglia in an Alzheimer's disease mouse model , 2018, Glia.
[29] D. Brooks,et al. Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET. , 2018, Journal of Alzheimer's disease : JAD.
[30] F. Jessen,et al. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE) , 2018, Alzheimer's Research & Therapy.
[31] Luca Passamonti,et al. Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy , 2018, Brain : a journal of neurology.
[32] R. Mizrahi,et al. Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[33] W. Jagust,et al. Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data , 2017, Data in brief.
[34] John L. Robinson,et al. TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss , 2017, Neuron.
[35] Paul Edison,et al. An early and late peak in microglial activation in Alzheimer’s disease trajectory , 2017, Brain : a journal of neurology.
[36] Yu Zhang,et al. The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional Architecture , 2016, Cerebral cortex.
[37] Paul Edison,et al. Neuroinflammation in Alzheimer's disease: Current evidence and future directions , 2016, Alzheimer's & Dementia.
[38] K. Blennow,et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers , 2016, EMBO molecular medicine.
[39] Paul Edison,et al. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease. , 2015, Brain : a journal of neurology.
[40] Jennifer Luebke,et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation , 2015, Nature Neuroscience.
[41] Claire Paquet,et al. Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study , 2015, Alzheimer's Research & Therapy.
[42] J. D. Kruschwitz,et al. GraphVar: A user-friendly toolbox for comprehensive graph analyses of functional brain connectivity , 2015, Journal of Neuroscience Methods.
[43] O. Garaschuk,et al. Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.
[44] R. Mayeux,et al. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease , 2013, Nature Neuroscience.
[45] Francis J McMahon,et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease. , 2013, Brain : a journal of neurology.
[46] Kimberly J. Jenko,et al. A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[47] Frederik Barkhof,et al. Microglial activation in healthy aging , 2012, Neurobiology of Aging.
[48] M. Giustetto,et al. Synaptic Pruning by Microglia Is Necessary for Normal Brain Development , 2011, Science.
[49] J. Growdon,et al. Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease. , 2011, The American journal of pathology.
[50] Christer Halldin,et al. Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [11C]vinpocetine , 2011, NeuroImage.
[51] Gerald van Belle,et al. Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): The first twenty years , 2008, Alzheimer's & Dementia.
[52] H. Braak,et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.
[53] M F Weiner,et al. A total score for the CERAD neuropsychological battery , 2005, Neurology.
[54] D. Mann,et al. Pathological relationships between microglial cell activity and tau and amyloid β protein in patients with Alzheimer's disease , 2002, Neuroscience Letters.
[55] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[56] D. Selkoe,et al. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease , 1989, Journal of Neuroimmunology.
[57] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[58] R. Innis,et al. Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia. , 2018, Advances in pharmacology.
[59] J. Sheridan,et al. Microglia Priming with Aging and Stress , 2017, Neuropsychopharmacology.
[60] Jan Sijbers,et al. ExploreDTI: a graphical toolbox for processing, analyzing, and visualizing diffusion MR data , 2009 .
[61] F. LaFerla,et al. Microglia as a potential bridge between the amyloid beta-peptide and tau. , 2004, Annals of the New York Academy of Sciences.